Effects of noradrenaline and dopamine injected into the supraoptic nucleus on urine flow rate in hydrated rats.
D000109:Acetylcholine / Q000494:pharmacology; D000613:Aminobutyrates / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D004231:Diuresis / Q000187:drug effects; D004298:Dopamine / Q000008:administration & dosage / Q000494:pharmacology*; D007031:Hypothalamus / Q000187:drug effects*; D007545:Isoproterenol / Q000494:pharmacology; D008236:Lypressin / Q000494:pharmacology; D008297:Male; D008845:Microinjections; D009638:Norepinephrine / Q000008:administration & dosage / Q000494:pharmacology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D013495:Supraoptic Nucleus / Q000187:drug effects* / Q000502:physiology; D014563:Urodynamics / Q000187:drug effects*
D000613:Aminobutyrates; D010643:Phenoxybenzamine; D012701:Serotonin; D008236:Lypressin; D001285:Atropine; D007545:Isoproterenol; D000109:Acetylcholine; D004298:Dopamine; D009638:Norepinephrine